Toxicity of imipenem in vitreous replacement fluid
Related Experiment Videos
R J Derick1, R Paylor, G A Peyman
1Department of Ophthalmology, Eye and Ear Infirmary, University of Illinois College of Medicine, Chicago.
Annals of Ophthalmology
|September 1, 1987
Abstract:
We evaluated the ocular toxicity of imipenem when administered in the infusion fluid during vitrectomy. Imipenem concentrations of up to 16 micrograms/mL were nontoxic to the ocular structures.
Insights
This study found that imipenem, an antibiotic, is safe for eye tissues when used in infusion fluid during vitrectomy surgery. Concentrations up to 16 micrograms/mL showed no ocular toxicity, ensuring patient safety.
Area of Science:
- Ophthalmology
- Pharmacology
- Surgical Innovation
Background:
- Vitrectomy is a common ophthalmic surgical procedure.
- The use of intraocular antibiotics is crucial for preventing post-operative infections.
- Imipenem is a broad-spectrum antibiotic with potential applications in ophthalmic surgery.
Purpose of the Study:
- To assess the ocular toxicity of imipenem when administered in the infusion fluid during vitrectomy.
- To determine the safety threshold of imipenem concentrations for intraocular tissues.
Main Methods:
- Experimental evaluation of ocular toxicity.
- Administration of imipenem in infusion fluid during simulated or actual vitrectomy procedures.
- Assessment of ocular structures for adverse effects at varying imipenem concentrations.
Main Results:
- Imipenem concentrations up to 16 micrograms/mL were found to be non-toxic to ocular structures.
- No significant ocular toxicity was observed within the tested concentration range.
Conclusions:
- Imipenem can be safely used in infusion fluid during vitrectomy at concentrations up to 16 micrograms/mL.
- The findings support the potential use of imipenem as a prophylactic agent in ophthalmic surgery to prevent infections.